Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
2.560
-0.050 (-1.92%)
At close: Apr 28, 2026, 4:00 PM EDT
2.670
+0.110 (4.30%)
After-hours: Apr 28, 2026, 4:57 PM EDT
Cellectar Biosciences Employees
Cellectar Biosciences had 11 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
11
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,981,003
Market Cap
10.85M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| CytoMed Therapeutics | 43 |
| Lunai Bioworks | 29 |
| Imunon | 25 |
| BioLineRx | 24 |
| Reviva Pharmaceuticals Holdings | 14 |
| BioVie | 13 |
| Kiora Pharmaceuticals | 13 |
| Traws Pharma | 7 |
CLRB News
- 14 days ago - Cellectar Enrolls First Patient in CLR 125 Auger-Emitting Radioconjugate Phase 1b Clinical Trial Targeting Refractory Triple Negative Breast Cancer (TNBC) - GlobeNewsWire
- 7 weeks ago - Cellectar Biosciences Earnings Call Transcript: Q4 2025 - Transcripts
- 7 weeks ago - Cellectar Biosciences Reports Financial Results for Year Ended 2025 and Provides Corporate Updates - GlobeNewsWire
- 2 months ago - Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Wednesday, March 4, 2026 - GlobeNewsWire
- 2 months ago - Cellectar Biosciences Expands Global Intellectual Property Estate - GlobeNewsWire
- 3 months ago - Cellectar Biosciences Transcript: 44th Annual J.P. Morgan Healthcare Conference - Transcripts
- 3 months ago - Cellectar Biosciences Transcript: Biotech Showcase 2026 - Transcripts
- 3 months ago - Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase during 44th Annual JP Morgan Healthcare Conference - GlobeNewsWire